Boris Calderon

Boris Calderon is a senior medical director specializing in global patient safety at Eli Lilly and Company. They possess extensive experience as a physician-scientist and immunologist, focusing on drug development, biomarkers, and pharmacovigilance. Boris's previous roles include staff scientist and medical director at the National Institutes of Health and assistant professor at Washington University School of Medicine. They completed a fellowship in clinical chemistry and a master's degree in health services while earning their MD from Universidad Nacional Autónoma de México.